Related Experiment Video
Updated: Aug 17, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Tuberculosis sequelae: clinical aspects]
S Harada1, Y Harada, Y Kitahara
1Ohmuta National Hospital, Fukuoka, Japan.
Abstract:
We studied the pulmonary diseases which had developed as consequent deformities after healing of tuberculosis, which we called tuberculosis sequelae. Results are described as follows. 1. The frequency of tuberculosis sequelae was about 6% in the patients with pulmonary diseases admitted to our hospital. 2. 93 cases of them consisted of 4 groups, which were 39 of repeated bacterial infection of lower respiratory tract, 23 of pulmonary aspergilloma, 13 of atypical mycobacteriosis and 28 of chronic respiratory failure. 3. Patients with tuberculosis sequelae were distributed more in the younger age group than others with resembled pulmonary diseases. The men to women ratio was about 2:1. Patients with pulmonary aspergilloma were younger than those with atypical mycobacteriosis. 4. Death rate in tuberculosis sequelae was about 5% per year. 46% of patients with atypical mycobacteriosis and 44% with chronic respiratory failure died within 4 years. 5. In chest X-ray findings, fibrosis and shrinkage of the lung, compensatory pulmonary emphysema, deformity or dilatation of bronchi, bulla formation and residual tuberculous cavities were recognized in 40 to 65% of the cases. Severe pleural thickness or past thoracoplasty were frequently recognized in the patients with chronic respiratory failure. All the patients with pulmonary aspergilloma had one or more residual cavities. 6. The frequency of systemic complications was not more than in the control population matched by age. Comparatively, serum IgG and IgA were elevated and PHA-induced lymphocyte activation was not lowered in the patients with pulmonary aspergilloma and atypical mycobacteriosis. From these results, the main factor in the development of tuberculosis sequelae seemed to be local defects of the chest.
Insights
Tuberculosis sequelae, or lung deformities after tuberculosis healing, affect about 6% of pulmonary disease patients. These conditions, including infections and chronic failure, are linked to local chest defects and have a significant mortality rate.
Area of Science:
- Pulmonology
- Infectious Diseases
- Medical Consequences of Tuberculosis
Context:
- Tuberculosis sequelae represent long-term pulmonary complications following tuberculosis (TB) treatment.
- Understanding these sequelae is crucial for managing chronic respiratory conditions and improving patient outcomes.
Purpose:
- To investigate the characteristics, clinical manifestations, and outcomes of tuberculosis sequelae.
- To identify risk factors and patterns associated with the development of these post-tuberculosis lung deformities.
Summary:
- Tuberculosis sequelae were identified in approximately 6% of pulmonary disease patients, encompassing repeated lower respiratory tract infections, pulmonary aspergilloma, atypical mycobacteriosis, and chronic respiratory failure.
- Patients with sequelae were younger, with a 2:1 male-to-female ratio. Pulmonary aspergilloma patients were younger than those with atypical mycobacteriosis. Mortality rates were significant, particularly for atypical mycobacteriosis and chronic respiratory failure.
- Chest X-rays revealed common findings like fibrosis, emphysema, bronchial deformities, and residual cavities. Systemic complications were comparable to controls, though specific immune markers were elevated in certain sequelae groups. Local chest defects appear to be a primary factor.
Impact:
- This study highlights the significant burden of tuberculosis sequelae, emphasizing the need for targeted monitoring and management strategies.
- Findings suggest that local thoracic structural defects play a key role in the pathogenesis of tuberculosis sequelae, informing future research and clinical practice.
More Related Videos
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
10:24Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis